Pulmonology Clinical Trials

Recruiting pulmonology studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat pulmonology. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting pulmonology studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting pulmonology trials

Within

Chronic COUGH Management in Interstitial Lung DisEase

for Interstitial Lung Disease

Sponsor: Aveiro University

Sex: All·Age: 18+

Code: NCT06782893

RSV Vaccination to Reduce Recurrent AECOPD

for COPD

Sponsor: Chinese University of Hong Kong

Sex: All·Age: 50+

Code: NCT07508644·Phase 4

Pulmonary Rehabilitation Frequency in COPD Patients

for COPD

Sponsor: Hospital Universitario Fundación Alcorcón

Sex: All·Age: All ages

Code: NCT07575841

Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers

for Cystic Fibrosis

1 site in Minneapolis

Sponsor: University of Minnesota

Sex: Female·Age: 18+

Code: NCT04940533

Dose-Escalation Study of Artesunate Patients With IPF

for Idiopathic Pulmonary Fibrosis

1 site in Stanford

Sponsor: Joseph C. Wu

Sex: All·Age: 40+

Code: NCT05988463·Phase 1

Apply to this trial

Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )

for Asthma

Sponsor: Indiana University

Sex: All·Age: 18 - 50

Code: NCT07179952·Phase 2

SMART-School-based Asthma Therapy

for Asthma in Children

Sponsor: University of Rochester

Sex: All·Age: 6 - 12

Code: NCT06796387

The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD

for Chronic Obstructive Pulmonary Disease

Sponsor: University of Alberta

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT04231760·Phase 1, Phase 2

Effect of add-on Doxofylline on Lung Function in Stable COPD

for Chronic Obstructive Pulmonary Disease

Sponsor: University of Milan

Sex: All·Age: 40+

Code: NCT04238221·Phase 4

Portable Positive Pressure Therapy Device

for COPD

Sponsor: Koronis Biomedical Technologies

Sex: All·Age: 21 - 85

Code: NCT04452851

Effect on Bronchodilation Response and Ventilation Heterogeneity of Different Inhalation Volumes in COPD

for COPD

Sponsor: University of Milan

Sex: All·Age: 40+

Code: NCT05381415

Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study

for Asthma

Sponsor: Hospital San Carlos, Madrid

Sex: All·Age: 18+

Code: NCT07635537

THERMotherapy Against Persistent Bacterial LUNG Infections

for Lung Diseases, Obstructive

Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Sex: All·Age: 18+

Code: NCT05351242

Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease

for Interstitial Lung Disease

Sponsor: Shanghai Life Science & Technology

Sex: All·Age: 18+

Code: NCT06534528·Phase 1

Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants

for Interstitial Lung Disease

Sponsor: Assistance Publique - Hôpitaux de Paris

Sex: All·Age: 18 - 80

Code: NCT07443436·Phase 2

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

9 sites incl. Birmingham

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 40 - 85

Code: NCT07674745·Phase 2

Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise

for COPD

Sponsor: Johns Hopkins University

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07686302

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

for Chronic Obstructive Pulmonary Disease

Sponsor: Eurofarma Laboratorios S.A.

Sex: All·Age: 40+

Code: NCT06234345·Phase 3

Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)

for Pulmonary Arterial Hypertension

Sponsor: University of Alberta

Sex: All·Age: 18+

Code: NCT07700303

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

for Asthma

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT07645248·Phase 3

Developing an Intervention to Optimize Virtual Care Adoption for COPD Management

for Chronic Obstructive Pulmonary Disease

2 sites incl. Bedford

Sponsor: VA Office of Research and Development

Sex: All·Age: 40+

Code: NCT05986214

Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension

for Pulmonary Arterial Hypertension

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18+

Code: NCT06176118·Phase 2

Immuno-inflammatory Response of Erdosteine in COPD

for COPD

Sponsor: Pierachille Santus, MD, PhD

Sex: All·Age: 45+

Code: NCT07329946

Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

for Interstitial Lung Disease

1 site in Buffalo

Sponsor: State University of New York at Buffalo

Sex: All·Age: 18 - 85

Code: NCT07512687

Apply to this trial

Screening and Management of Adults With Asthma and Allergic Diseases

for Asthma

Sponsor: Beijing Hospital

Sex: All·Age: 18 - 60

Code: NCT07523724

Dynamic Changes in Right Ventricle and Pulmonary Artery Coupling Among COPD Patients With Acute Exacerbation

for COPD Exacerbation (AECOPD)

Sponsor: Assiut University

Sex: All·Age: 40+

Code: NCT07694713

Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis

for Systemic Sclerosis

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Sex: All·Age: 45 - 75·Accepts healthy volunteers

Code: NCT07717060

TEPH: Telaglenastat Efficacy in Pulmonary Hypertension

for Pulmonary Hypertension

1 site in Pittsburgh

Sponsor: Chan, Stephen, MD, PhD

Sex: All·Age: 18 - 75

Code: NCT07223528·Phase 1, Phase 2

Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function

for Cystic Fibrosis

2 sites in Atlanta

Sponsor: Emory University

Sex: All·Age: 2 Weeks - 90

Code: NCT07414810

A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)

for Pulmonary Arterial Hypertension

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 1 - 17

Code: NCT07646860·Phase 2

Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis

Sponsor: InSilico Medicine Hong Kong Limited

Sex: All·Age: 40+

Code: NCT07687459·Phase 3

Pulmonary Hypertension (PH) Biorepository for Translational Research

for Pulmonary Hypertension

3 sites incl. Baltimore

Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All·Age: 18 - 100

Code: NCT07647549

SBAT for Health Equity

for Asthma in Children

Sponsor: University of Rochester

Sex: All·Age: 4 - 12

Code: NCT05744869

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

1 site in Worcester

Sponsor: University of Massachusetts, Worcester

Sex: All·Age: 40+

Code: NCT07520110·Phase 3

Outpatient Rehabilitation Programmes for Myocardial Ischemia, Heart Failure, and COPD: Satisfaction, Participation, Test Outcomes, and Factors Associated With Positive Changes in Test Results as Well as Level of Participation

for Heart Disease

Sponsor: Nordsjaellands Hospital

Sex: All·Age: 18+

Code: NCT07591792

Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,

for Anesthesia

Sponsor: Fondation Hôpital Saint-Joseph

Sex: All·Age: 18+

Code: NCT07614438·Phase 2

Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial Prospective

for Congenital Heart Disease

Sponsor: The University of Hong Kong

Sex: All·Age: 20 - 70

Code: NCT07663799

Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD

for COPD

Sponsor: Capital Development Authority (CDA) Hospital Islamabad

Sex: All·Age: 18 - 90

Code: NCT07708337

Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD

for Heart Failure

7 sites incl. Phoenix

Sponsor: VA Office of Research and Development

Sex: All·Age: 18+

Code: NCT07714252

Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

for Asthma

6 sites incl. New Haven

Sponsor: Brigham and Women's Hospital

Sex: All·Age: 18 - 75

Code: NCT06596512

Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department

for Asthma

1 site in The Bronx

Sponsor: Montefiore Medical Center

Sex: All·Age: 18+

Code: NCT07228052·Phase 4

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

for Dermatomyositis

1 site in Miami

Sponsor: University of Miami

Sex: All·Age: 18+

Code: NCT07486869·Phase 2

MedlyPeds Feasibility Study

for Pediatric Heart Failure

Sponsor: The Hospital for Sick Children

Sex: All·Age: 8 - 18

Code: NCT07556185

Apply to this trial

A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

for Idiopathic Pulmonary Fibrosis (IPF)

1 site in Norfolk

Sponsor: Cosmos Rx, Inc

Sex: All·Age: 21+

Code: NCT07613216

A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease

for Chronic Obstructive Pulmonary Disease

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Sex: All·Age: 40 - 75

Code: NCT07633314·Phase 2

Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate

for Asthma

1 site in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07664527·Phase 4

Quantifying the Burden of Type 2 (T2) Inflammation in Asthma

for Asthma

1 site in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+

Code: NCT07675044

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

for Pulmonary Hypertension

3 sites incl. Houma

Sponsor: Pulnovo Medical, Inc.

Sex: All·Age: 18 - 85

Code: NCT07214376

Apply to this trial

A Study to Evaluate the Diagnostic Performance of Portable Oscillometry Across Chronic Respiratory Diseases

for COPD

Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Sex: All·Age: 3+·Accepts healthy volunteers

Code: NCT07631507

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

for Allogeneic Stem Cell Transplantation

1 site in Bethesda

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All·Age: 18 - 100

Code: NCT07613099·Phase 3

Apply to this trial

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

for Asthma

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 60·Accepts healthy volunteers

Code: NCT07712393·Phase 1

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

for Bronchopulmonary Dysplasia

2 sites incl. Birmingham

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 1 Month - 5 Months·Accepts healthy volunteers

Code: NCT06373289

Apply to this trial

A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

for Pulmonary Arterial Hypertension

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07600723·Phase 4

Effects of Adapted Snacktivity™ Intervention on Cognition and Self-Care in COPD Patients

for COPD

Sponsor: The University of Hong Kong

Sex: All·Age: 60+

Code: NCT07702994

A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD

for COPD

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07567872·Phase 1

Apply to this trial

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis

Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All·Age: 40+

Code: NCT07516951·Phase 2

Apply to this trial

A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia

for Pulmonary Hypertension

11 sites incl. Durham

Sponsor: Duke University

Sex: All·Age: 18+

Code: NCT06327373·Phase 1, Phase 2

Evaluating the EAPOC-COPD System

for COPD

Sponsor: Women's College Hospital

Sex: All·Age: 18+

Code: NCT06852339

Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

for Pulmonary Arterial Hypertension

Sponsor: NS Pharma, Inc.

Sex: All·Age: 18 - 75

Code: NCT07441200·Phase 2

COPD Flare-Up Clinic After Severe Exacerbations

for COPD

Sponsor: Tel-Aviv Sourasky Medical Center

Sex: All·Age: 40 - 80

Code: NCT07629869

Pulmonology clinical trials — common questions

Are pulmonology clinical trials free to join?

Yes. Participating in a pulmonology clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a pulmonology clinical trial?

Each pulmonology study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a pulmonology trial near me?

Use the location controls above. We'll show recruiting pulmonology trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many pulmonology trials are recruiting right now?

We're currently tracking roughly 368 recruiting pulmonology trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Pulmonology trials by city

Birmingham, AL Aurora, CO Boston, MA Los Angeles, CA Cincinnati, OH Denver, CO San Francisco, CA Chicago, IL Cleveland, OH Madison, WI Miami, FL Oklahoma City, OK

Conditions in this area

Asthma COPD Cystic fibrosis Interstitial lung disease Idiopathic pulmonary fibrosis Pulmonary hypertension